
Michael Pervan
Examiner (ID: 11308, Phone: (571)272-0910 , Office: P/2621 )
| Most Active Art Unit | 2621 |
| Art Unit(s) | 2693, 2677, 2691, 2629, 2621 |
| Total Applications | 1288 |
| Issued Applications | 1041 |
| Pending Applications | 53 |
| Abandoned Applications | 213 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6248659
[patent_doc_number] => 20100137192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/555895
[patent_app_country] => US
[patent_app_date] => 2009-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23406
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137192.pdf
[firstpage_image] =>[orig_patent_app_number] => 12555895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555895 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS | Sep 8, 2009 | Abandoned |
Array
(
[id] => 6372598
[patent_doc_number] => 20100080782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Use of probiotic lactic acid bacteria for balancing the skin\'s immune system'
[patent_app_type] => utility
[patent_app_number] => 12/454722
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5086
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20100080782.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454722
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454722 | Use of probiotic lactic acid bacteria for balancing the skin's immune system | Aug 6, 2009 | Issued |
Array
(
[id] => 6063073
[patent_doc_number] => 20110201023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'MANNOSE 6-PHOSPHATE-BINDING ANTIBODIES AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/057844
[patent_app_country] => US
[patent_app_date] => 2009-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10741
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201023.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057844
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057844 | MANNOSE 6-PHOSPHATE-BINDING ANTIBODIES AND THEIR USES | Aug 5, 2009 | Abandoned |
Array
(
[id] => 6550461
[patent_doc_number] => 20100233181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/533501
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 24111
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12533501
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/533501 | Antibodies against clostridium difficile toxins and uses thereof | Jul 30, 2009 | Issued |
Array
(
[id] => 6550479
[patent_doc_number] => 20100233182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Antibodies against Clostridium difficile toxins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/533552
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 24108
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233182.pdf
[firstpage_image] =>[orig_patent_app_number] => 12533552
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/533552 | Antibodies against Clostridium difficile toxins and uses thereof | Jul 30, 2009 | Issued |
Array
(
[id] => 6549768
[patent_doc_number] => 20100016572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen'
[patent_app_type] => utility
[patent_app_number] => 12/458388
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11334
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016572.pdf
[firstpage_image] =>[orig_patent_app_number] => 12458388
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/458388 | Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen | Jul 9, 2009 | Abandoned |
Array
(
[id] => 6062293
[patent_doc_number] => 20110200640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'MULTIVALENT ANTIHELMINTHIC VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/999132
[patent_app_country] => US
[patent_app_date] => 2009-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 5963
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20110200640.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999132
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999132 | Multivalent antihelminthic vaccine | Jun 29, 2009 | Issued |
Array
(
[id] => 5943444
[patent_doc_number] => 20110104064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'CYCLIZED NON-NATIVE SYNTHETIC PEPTIDE AND COMPLEX OF PEPTIDES COMPRISING SAID CYCLIZED PEPTIDE, INTENDED TO INDUCE AND TO CHARACTERIZE THE PREVENTION OR TREATMENT OF CONDITIONS IN MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 12/999334
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6570
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104064.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999334
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999334 | CYCLIZED NON-NATIVE SYNTHETIC PEPTIDE AND COMPLEX OF PEPTIDES COMPRISING SAID CYCLIZED PEPTIDE, INTENDED TO INDUCE AND TO CHARACTERIZE THE PREVENTION OR TREATMENT OF CONDITIONS IN MAMMALS | Jun 17, 2009 | Abandoned |
Array
(
[id] => 12044575
[patent_doc_number] => 09822167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Probiotics, secretory IgA and inflammation'
[patent_app_type] => utility
[patent_app_number] => 13/000666
[patent_app_country] => US
[patent_app_date] => 2009-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4419
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13000666
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000666 | Probiotics, secretory IgA and inflammation | Jun 15, 2009 | Issued |
Array
(
[id] => 9427082
[patent_doc_number] => 08703152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Methods of treating inflammatory intestinal disease and managing symptoms thereof'
[patent_app_type] => utility
[patent_app_number] => 12/996166
[patent_app_country] => US
[patent_app_date] => 2009-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 27
[patent_no_of_words] => 17750
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12996166
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996166 | Methods of treating inflammatory intestinal disease and managing symptoms thereof | Jun 2, 2009 | Issued |
Array
(
[id] => 8171332
[patent_doc_number] => 20120107349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'MULTIVALENT NANOEMULSION VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/472218
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 46561
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107349.pdf
[firstpage_image] =>[orig_patent_app_number] => 12472218
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/472218 | Multivalent nanoemulsion vaccines | May 25, 2009 | Issued |
Array
(
[id] => 6046819
[patent_doc_number] => 20110206716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'SYNERGISTIC IMMUNOGENIC FUSION PROTEIN-POLYSACCHARIDE CONJUGATE'
[patent_app_type] => utility
[patent_app_number] => 12/992282
[patent_app_country] => US
[patent_app_date] => 2009-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12029
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20110206716.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992282
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992282 | Synergistic immunogenic fusion protein-polysaccharide conjugate | May 21, 2009 | Issued |
Array
(
[id] => 6110375
[patent_doc_number] => 20110189236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria'
[patent_app_type] => utility
[patent_app_number] => 12/990264
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 31197
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990264
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990264 | Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria | May 7, 2009 | Abandoned |
Array
(
[id] => 5538763
[patent_doc_number] => 20090220568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'METHODS FOR TREATING A STRICTURE WITH A BOTULINUM TOXIN'
[patent_app_type] => utility
[patent_app_number] => 12/436730
[patent_app_country] => US
[patent_app_date] => 2009-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10233
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220568.pdf
[firstpage_image] =>[orig_patent_app_number] => 12436730
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/436730 | METHODS FOR TREATING A STRICTURE WITH A BOTULINUM TOXIN | May 5, 2009 | Abandoned |
Array
(
[id] => 8264750
[patent_doc_number] => 20120164178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/936953
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24107
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/936953 | Vaccine | Apr 15, 2009 | Abandoned |
Array
(
[id] => 5929806
[patent_doc_number] => 20110039765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Bioactive Molecules Produced by Probiotic Bacteria'
[patent_app_type] => utility
[patent_app_number] => 12/937417
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5385
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039765.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937417 | Bioactive Molecules Produced by Probiotic Bacteria | Mar 8, 2009 | Abandoned |
Array
(
[id] => 8398602
[patent_doc_number] => 08268981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Plasmodium malariae and plasmodium ovale genes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/397558
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 37048
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12397558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/397558 | Plasmodium malariae and plasmodium ovale genes and uses thereof | Mar 3, 2009 | Issued |
Array
(
[id] => 10869822
[patent_doc_number] => 08895014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells'
[patent_app_type] => utility
[patent_app_number] => 12/735773
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 18840
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735773
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735773 | Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells | Feb 18, 2009 | Issued |
Array
(
[id] => 9388820
[patent_doc_number] => 08685413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Heterologous protection against Pasteurella multocida provided by P. multocida fur cells and the outer-membrane protein extracts thereof'
[patent_app_type] => utility
[patent_app_number] => 12/865287
[patent_app_country] => US
[patent_app_date] => 2009-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10086
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865287 | Heterologous protection against Pasteurella multocida provided by P. multocida fur cells and the outer-membrane protein extracts thereof | Jan 28, 2009 | Issued |
Array
(
[id] => 6184164
[patent_doc_number] => 20110123629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'TARGETING OF INNATE IMMUNE RESPONSE TO TUMOR SITE'
[patent_app_type] => utility
[patent_app_number] => 12/864550
[patent_app_country] => US
[patent_app_date] => 2009-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7799
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123629.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864550 | Targeting of innate immune response to tumor site | Jan 24, 2009 | Issued |